Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition–resistant triple-negative breast cancer cells

Larissa Menezes dos Reis, Douglas Adamóski, Rodolpho Ornitz Oliveira Souza, Carolline Ascenção, Krishina Oliveira, Felipe Corrêa‐da‐Silva, Fábio Malta de Sá Patroni, Marília M. Dias, Sílvio Roberto Consonni, Ariel Mariano Silber,

Journal of Biological Chemistry · 2019 · 87 citations · 60 references

DOIFull text

Open access

Concepts

Abstract

) gene expression. Of note, CB-839-resistant TNBC cells had increased carnitine palmitoyltransferase 2 (CPT2) protein and CPT1 activity levels. In agreement, CB-839-resistant TNBC cells mobilized more fatty acids into mitochondria for oxidation, which responded to AMP-activated protein kinase and acetyl-CoA carboxylase signaling. Moreover, chemical inhibition of both glutaminase and CPT1 decreased cell proliferation and migration of CB-839-resistant cells compared with single inhibition of each enzyme. We propose that dual targeting of glutaminase and CPT1 activities may have therapeutic relevance for managing CB-839-resistant tumors.

References

60